Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Molecular Therapy. Methods & Clinical Development
|
November 26, 2019
Immunoresponse to Gene-Modified Hematopoietic Stem Cells
Claire M Drysdale, John F Tisdale, Naoya Uchida
Cell Stem Cell
|
February 5, 2021
Hematopoietic-Stem-Cell-Targeted Gene-Addition and Gene-Editing Strategies for β-hemoglobinopathies
Claire M Drysdale, Tina Nassehi, Jackson Gamer, et al.
Cytotherapy
|
December 1, 2019
Ex vivo immunological evaluation of stable mixed chimeric patients after matched related donor allogeneic transplantation in sickle cell disease
Lydia N Raines, Matthew M Hsieh, Tina Nassehi, et al.
Molecular Therapy. Methods & Clinical Development
|
February 22, 2019
High-Efficiency Lentiviral Transduction of Human CD34<sup>+</sup> Cells in High-Density Culture with Poloxamer and Prostaglandin E2
Naoya Uchida, Tina Nassehi, Claire M Drysdale, et al.
Molecular Therapy. Methods & Clinical Development
|
January 1, 2020
Low-Dose Busulfan Reduces Human CD34<sup>+</sup> Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient Mice
Alexis Leonard, Morgan Yapundich, Tina Nassehi, et al.
Molecular Therapy. Methods & Clinical Development
|
April 5, 2021
Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
Naoya Uchida, Claire M Drysdale, Tina Nassehi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 30, 2019
Busulfan Combined with Immunosuppression Allows Efficient Engraftment of Gene-Modified Cells in a Rhesus Macaque Model
Naoya Uchida, Tina Nassehi, Claire M Drysdale, et al.
Cell Reports. Medicine
|
May 5, 2021
Preclinical evaluation for engraftment of CD34<sup>+</sup> cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate models
Naoya Uchida, Linhong Li, Tina Nassehi, et al.
Science Translational Medicine
|
April 29, 2021
Sustained fetal hemoglobin induction in vivo is achieved by <i>BCL11A</i> interference and coexpressed truncated erythropoietin receptor
Naoya Uchida, Francesca Ferrara, Claire M Drysdale, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Molecular Therapy. Methods & Clinical Development
|
November 26, 2019
Immunoresponse to Gene-Modified Hematopoietic Stem Cells
Claire M Drysdale, John F Tisdale, Naoya Uchida
Cell Stem Cell
|
February 5, 2021
Hematopoietic-Stem-Cell-Targeted Gene-Addition and Gene-Editing Strategies for β-hemoglobinopathies
Claire M Drysdale, Tina Nassehi, Jackson Gamer, et al.
Cytotherapy
|
December 1, 2019
Ex vivo immunological evaluation of stable mixed chimeric patients after matched related donor allogeneic transplantation in sickle cell disease
Lydia N Raines, Matthew M Hsieh, Tina Nassehi, et al.
Molecular Therapy. Methods & Clinical Development
|
February 22, 2019
High-Efficiency Lentiviral Transduction of Human CD34<sup>+</sup> Cells in High-Density Culture with Poloxamer and Prostaglandin E2
Naoya Uchida, Tina Nassehi, Claire M Drysdale, et al.
Molecular Therapy. Methods & Clinical Development
|
January 1, 2020
Low-Dose Busulfan Reduces Human CD34<sup>+</sup> Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient Mice
Alexis Leonard, Morgan Yapundich, Tina Nassehi, et al.
Molecular Therapy. Methods & Clinical Development
|
April 5, 2021
Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
Naoya Uchida, Claire M Drysdale, Tina Nassehi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 30, 2019
Busulfan Combined with Immunosuppression Allows Efficient Engraftment of Gene-Modified Cells in a Rhesus Macaque Model
Naoya Uchida, Tina Nassehi, Claire M Drysdale, et al.
Cell Reports. Medicine
|
May 5, 2021
Preclinical evaluation for engraftment of CD34<sup>+</sup> cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate models
Naoya Uchida, Linhong Li, Tina Nassehi, et al.
Science Translational Medicine
|
April 29, 2021
Sustained fetal hemoglobin induction in vivo is achieved by <i>BCL11A</i> interference and coexpressed truncated erythropoietin receptor
Naoya Uchida, Francesca Ferrara, Claire M Drysdale, et al.
Page
of 1